Found: 16
Select item for more details and to access through your institution.
Cathepsin S-mediated autophagic flux in tumor-associated macrophages accelerate tumor development by promoting M2 polarization.
- Published in:
- Molecular Cancer, 2014, v. 13, n. 1, p. 1, doi. 10.1186/1476-4598-13-43
- By:
- Publication type:
- Article
Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123175
- By:
- Publication type:
- Article
Development of Serous Ovarian Cancer is Associated with the Expression of Homologous Recombination Pathway Proteins.
- Published in:
- Pathology & Oncology Research, 2014, v. 20, n. 4, p. 931, doi. 10.1007/s12253-014-9776-8
- By:
- Publication type:
- Article
Development of Serous Ovarian Cancer is Associated with the Expression of Homologous Recombination Pathway Proteins.
- Published in:
- Pathology & Oncology Research, 2014, v. 20, n. 2, p. 1, doi. 10.1007/s12253-014-9776-8
- By:
- Publication type:
- Article
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-241
- By:
- Publication type:
- Article
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-168
- By:
- Publication type:
- Article
The AKT inhibitor AZD5363 is selectively active in PI3KCA mutant gastric cancer, and sensitizes a patient-derived gastric cancer xenograft model with PTEN loss to Taxotere.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models.
- Published in:
- Journal of Translational Medicine, 2012, v. 10, n. 1, p. 180, doi. 10.1186/1479-5876-10-180
- By:
- Publication type:
- Article
An evaluation and recommendation of the optimal methodologies to detect RET gene rearrangements in papillary thyroid carcinoma.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 3, p. 168, doi. 10.1002/gcc.22229
- By:
- Publication type:
- Article
Whole genome gene copy number profiling of gastric cancer identifies PAK1 and KRAS gene amplification as therapy targets.
- Published in:
- Genes, Chromosomes & Cancer, 2014, v. 53, n. 11, p. 883, doi. 10.1002/gcc.22196
- By:
- Publication type:
- Article
Recurrent amplification of MYC and TNFRSF11B in 8q24 is associated with poor survival in patients with gastric cancer.
- Published in:
- Gastric Cancer, 2016, v. 19, n. 1, p. 116, doi. 10.1007/s10120-015-0467-2
- By:
- Publication type:
- Article
Identification and validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target in squamous cell lung and esophageal carcinoma.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1455-y
- By:
- Publication type:
- Article
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
- Published in:
- BMC Cancer, 2015, v. 15, n. 1, p. 1, doi. 10.1186/s12885-015-1146-8
- By:
- Publication type:
- Article
A retrospective analysis of RET translocation, gene copy number gain and expression in NSCLC patients treated with vandetanib in four randomized Phase III studies.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Proliferative and Antiapoptotic Signaling Stimulated by Nuclear-Localized PDK1 Results in Oncogenesis.
- Published in:
- Science Signaling, 2012, v. 5, n. 249, p. 1, doi. 10.1126/scisignal.2003065
- By:
- Publication type:
- Article